SWX/BSX (SWX/BSX)

SIX Swiss Exchange: SWX/BSX · CHF

CHF 35.7

+0.59 (+1.7%)· Recorded snapshot

Market cap	52.6B
Revenue (ttm)	17.6B
Net income (ttm)	2.9B
EPS (ttm)	CHF 1.94
P/E (trailing)	18.4x
P/E (forward)	14.4x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 17.6B
Net income (ttm): 2.9B
EPS (ttm): CHF 1.94
P/E (trailing): 18.4x
P/E (forward): 14.4x
Market cap: 52.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-03 14:30 UTC

Forward P/E14.4

P25 n/aP50 n/aP75 n/a

Trailing P/E18.4

P25 n/aP50 n/aP75 n/a

ROE15.3

P25 n/aP50 n/aP75 n/a

ROIC10.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SWX/BSX indicators

Market & fundamental data

Available fields

199

Groups with data

Currency

USD

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CHF
Country	United States
Country code	CH
Earnings date	2026-10-28
Employees	59,000
Employees change	6,000
Employees growth	11.32%
Enterprise value	CHF 62.7B
Exchange	SIX Swiss Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-10-10
Fiscal year end	December
Founded	1979
Industry	Medical Devices
Is primary listing	No
ISIN number	US1011371077
Last earnings date	2026-10-28
Last refreshed	2026-11-03
Market cap	CHF 52.6B
Next earnings date	2027-02-03
Price	CHF 35.71
Price currency	CHF
Sector	Healthcare
SIC code	3845
Stock price date	2026-11-02
Symbol	swx/BSX
Website	https://www.bostonscientific.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	76.84x
Average P/E ratio (3Y)	50.98x
Average P/E ratio (5Y)	62.9x
Earnings yield	5.43%
EV/Earnings	21.47x
EV/EBIT	17.95x
EV/EBITDA	13.45x
EV/FCF	21.14x
EV/Sales	3.63x
FCF / EV yield	4.73%
FCF yield	5.64%
Forward P/E	14.37x
Graham number	25.21237
Graham upside	-29.39%
Industry P/E	42.37x
Lynch fair value	CHF 49.56
Lynch upside	38.81%
P/(FCF - SBC) ratio	19.46x
P/(OCF - SBC) ratio	15.28x
P/B ratio	2.51x
P/E ratio	18.43x
P/FCF ratio	17.74x
P/OCF ratio	14.2x
P/S ratio	2.99x
Price/EBITDA ratio	11.08x
Sector forward P/E	19.83x
Sector P/E	34.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	20.24%
EBITDA margin	27.02%
Effective tax rate	4.43%
FCF margin	17.27%
Gross margin	68.58%
Operating margin	20.24%
Pretax margin	17.35%
Profit margin	16.62%
Profit per employee	CHF 49,523
Profitable quarters	24
Profitable years	5
Revenue per employee	CHF 297,958
ROA	6.19%
ROA (5Y)	4.61%
ROCE	11.08%
ROE	15.34%
ROE (5Y)	8.1%
ROIC	10.94%
ROIC (5Y)	7.52%
SBC / revenue	1.52%
Tax / revenue	0.77%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	26.63%
EPS growth (Q)	-21.5%
EPS growth (QoQ)	-34.43%
EPS growth 10Y	46.25%
EPS growth 3Y	42.32%
EPS growth 5Y	25.24%
EPS growth years	3
FCF growth	4.02%
FCF growth 3Y	33.93%
FCF growth 5Y	14.35%
Gross profit growth	8.31%
Gross profit growth (Q)	-1.5%
Gross profit growth 3Y	15%
Gross profit growth 5Y	12.36%
Net income growth	25.48%
Net income growth (Q)	-22.91%
Net income growth (QoQ)	-35.83%
Net income growth 3Y	43.26%
Net income growth 5Y	26.04%
Net income growth years	3
OCF growth	5.69%
OCF growth 10Y	13.52%
OCF growth 3Y	28.69%
OCF growth 5Y	15.09%
Operating income growth	11.07%
Operating income growth (Q)	-0.95%
Operating income growth 3Y	22.39%
Operating income growth 5Y	16.59%
Revenue growth	8.89%
Revenue growth (Q)	1.44%
Revenue growth (QoQ)	-5.59%
Revenue growth 10Y	10.04%
Revenue growth 3Y	15.27%
Revenue growth 5Y	12.93%
Revenue growth quarters	23
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CHF -739.8M
Depreciation and amortization	CHF 1.2B
EBIT	CHF 3.6B
EBITDA	CHF 4.8B
EPS	CHF 1.94
Financing cash flow	CHF -784M
Free cash flow	CHF 3B
Free cash flow minus SBC	CHF 2.7B
Gross profit	CHF 12.1B
Income taxes	CHF 135.2M
Investing cash flow	CHF -2.9B
Net borrowing	CHF 800.4M
Net cash flow	CHF 9.8M
Net income	CHF 2.9B
Operating cash flow minus SBC	CHF 3.4B
Operating income	CHF 3.6B
Revenue	CHF 17.6B
Stock-based compensation	CHF 261.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CHF 14.38
Debt / EBITDA	2.22
Debt / equity	0.5
Debt / FCF	3.55
Interest coverage	11.37
Net cash (debt)	CHF -10.1B
Net cash / market cap	-19.16%
Net debt / EBITDA	2.12
Net debt / equity	0.48
Net debt / FCF	3.4
Piotroski F-Score	5
Shareholders' equity	CHF 21B
Tangible book value	CHF -524M
Tangible book value per share	CHF -0.36
Total cash	CHF 449.7M
Total debt	CHF 10.5B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current ratio	1.24
Inventory turnover	2.12
Quick ratio	0.56
Working capital	CHF 1.3B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.91%
Shareholder yield	0.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CHF 39.57
1D price change	1.67%
1M price change	-0.94%
1M total return	-0.94%
1W price change	-4.58%
1W total return	-4.58%
20-day SMA	CHF 36.11
200-day SMA	CHF 44.71
3M price change	-2.07%
3M total return	-2.07%
50-day SMA	CHF 36.69
50-day SMA vs 200-day SMA	50under200
52-week high	CHF 80.37
52-week high date	2025-12-04
52-week low	CHF 34.54
52-week low date	2026-06-30
6M price change	-20.34%
6M total return	-20.34%
All-time high	CHF 80.37
All-time high date	2025-12-01
All-time low	CHF 34.54
All-time low date	2026-06-30
Average true range (ATR)	CHF 0.51
Average volume	0
Change from 52-week high	-55.57%
Change from 52-week low	3.37%
Change from all-time high	-55.57%
Change from all-time low	3.37%
Monthly RSI	0
Previous close	CHF 35.12
Price vs 150-day SMA	-9.77%
Price vs 20-day SMA	-1.13%
Price vs 200-day SMA	-20.14%
Price vs 50-day SMA	-2.69%
RSI	45.34
Sharpe ratio	-2.51
Sortino ratio	-2.79
Weekly RSI	36.01
YTD price change	-53.12%
YTD total return	-53.12%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.4B
Shares change (QoQ)	-1.55%
Shares change (YoY)	-0.91%
Shares held by insiders	0.18%
Shares held by institutions	93.36%
Short ratio	2.1 days

Deeper analysis on SWX/BSX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SWX/BSX report

Is a complete SWX/BSX research report available?

No complete published report is available for swx/BSX (SWX/BSX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SWX/BSX (SWX/BSX)

Price

Financial snapshot

Fair-value bridge

Latest news · SWX/BSX

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All SWX/BSX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SWX/BSX

Frequently asked questions